In this article, I examine and question the phenomenon of “the urine drop-off”-having the patient with suspected UTI collect a urine sample at home and drop it off at the practice-in the context of best clinical practice, common sense, and basic office efficiency.
While women are far more likely to suffer from urinary tract infections, men are more likely to be hospitalized for treatment, according to a study by urologists from Henry Ford Hospital in Detroit.
The latest products and services from Cook Medical, American Medical Systems, Dialog Medical, Astellas Pharma U.S., Giffen Solutions, the Société Internationale d’Urologie, Merck Consumer Care, and the Bladder Cancer Advocacy Network.
In this interview, Brian R. Matlaga, MD, MPH, discusses factors to consider in the decision to utilize ureteroscopy versus shock wave lithotripsy, how to counsel patients on the optimal approach, how to minimize the morbidity of each modality, and why younger urologists are more likely to perform ureteroscopy.
The American Society for Radiation Oncology and the American Academy of Family Physicians have both released recommendations on the diagnosis and treatment of prostate cancer as part of the Choosing Wisely campaign.
A recent study has shown that in women with moderate-to-severe stress urinary incontinence, surgery is more effective than physiotherapy.
Following suburethral mesh sling removal, half of patients had operations to treat incontinence, according to a study reported at the AUA annual meeting in San Diego.
Three different procedures to treat stress urinary incontinence led to high rates of recurrence-free outcomes at 5 years, and the choice of retreatment of SUI varied according to the initial procedure, long-term follow-up in two randomized trials showed.
Need for a repeat voiding trial after midurethral sling surgery does not increase the likelihood of a suboptimal outcome and may even predict a better long-term result, say researchers from the Urinary Incontinence Treatment Network.
The FDA has authorized the marketing of the UroLift system, the first permanent implant to relieve low or blocked urine flow in men aged 50 years and older with BPH.
Houston-based Texas Children’s Hospital has opened a new pediatric stone clinic to provide comprehensive care for children and adolescents with kidney stones.
The risk of women developing kidney stones is rising, as is the number of cases being seen in U.S. emergency departments, while the rate of hospitalization for the disorder has remained stable, recent study findings indicate.
Total annual costs for major health care-associated infections (HAIs) were estimated at $9.8 billion in a recent study, with catheter-associated urinary tract infections representing
Most urologists agree that surgical removal of the enlarged portion of the prostate is the most effective and durable way to manage lower urinary tract symptoms in men secondary to BPH. Where it gets interesting is deriving urologic consensus on the best way to achieve that goal.
Could bacteria in the lower urinary tract play a role in urologic chronic pelvic pain syndrome (CPPS)? The jury is still out, but the authors of a new study say they weren’t able to find any evidence that germs are at fault.
A new study has found that testosterone replacement doesn’t worsen lower urinary tract symptoms related to an enlarged prostate. In fact, many men saw their symptoms improve, apparently with little effect on their prostate gland.
The latest products and services from neoSurgical, Wiley-Blackwell, iURO, and USARAD.com.
As follow-up lengthens in a prospective, randomized, controlled trial, men who underwent bipolar plasma vaporization of the prostate for BPH using the “button” vapo-resection electrode continue to demonstrate significantly better symptom scores and voiding characteristics compared to their counterparts treated by bipolar transurethral resection in saline or monopolar transurethral resection of the prostate.
In the treatment of BPH, while both bipolar-transurethral resection of the prostate (B-TURP) and monopolar-TURP (M-TURP) have similar clinical efficacy, B-TURP is associated with fewer adverse events, according to a recent systematic review of the two modalities.
A minimally invasive implant procedure led to a 50% improvement in lower urinary tract symptoms due to BPH, which was maintained for a year, results of a randomized trial showed.
An analysis of data from three studies that involved a total of more than 240,000 participants found that a self-reported history of kidney stones was associated with a statistically significant increased risk of coronary heart disease among women.
Drugs and devices in the pipeline from Targacept, Inc., Cubist, OncoGenex Pharmaceuticals, Inc., Apricus Biosciences, and Nymox Pharmaceutical Corp.
New products and services from GenomeDx Biosciences, the Coding Institute, Astellas Pharma US, Greenbranch Publishing, the National Association for Continence, Perrigo Co., the Bladder Cancer Advocacy Network, and the Brewer Co.
Bruce R. Kava, MD, presents the take home messages on BPH/LUTS from the AUA annual meeting in San Diego.
Mantu Gupta, MD, presents the take home messages on stone disease/endourology from the AUA annual meeting in San Diego.
